FOLD- Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Activity
Buys and sells only
Transactions
10 filings · page 30
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2018 | Barth Jay | Chief Medical Officer | Sale+OE | 20,000 | $16.80 | $336,000.00 | -19.0% | |
| Jan 22, 2018 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 32,500 | $15.92 | $517,370.75 | -17.4% | |
| Jan 2, 2018 | Andrews Kurt J. | SVP, Human Resources | Sale+OE | 10,000 | $14.72 | $147,191.00 | -22.4% | |
| Jan 2, 2018 | Barth Jay | Chief Medical Officer | Sale+OE | 5,000 | $14.71 | $73,559.00 | -7.2% | |
| Jan 2, 2018 | Baird William D III | Chief Financial Officer | Sale+OE | 10,000 | $14.72 | $147,181.00 | -9.5% | |
| Jan 2, 2018 | Quimi Daphne58 | SVP, Finance | Sale+OE | 8,000 | $14.72 | $117,723.20 | -12.8% | |
| Jan 2, 2018 | Hayden Donald J Jr | Director | Sale+OE | 20,000 | $15.00 | $300,002.00 | -77.5% | |
| Jan 2, 2018 | Raab Michael56 | Director | Sale+OE | 9,366 | $15.00 | $140,490.00 | -61.7% | |
| Dec 29, 2017 | Crowley John F67 | Chairman &CEO | Sale+OE | 18,970 | $14.75 | $279,816.64 | -2.8% | |
| Dec 21, 2017 | Crowley John F67 | Chairman &CEO | Sale+OE | 65,581 | $13.51 | $885,764.53 | -9.1% |